Véronique Trochon

Title: Innovations of Véronique Trochon in Angiogenesis Inhibition

Introduction

Véronique Trochon is a notable inventor based in Paris, France. She has made significant contributions to the field of medical research, particularly in the area of inhibiting angiogenesis and metastasis formation. Her work is crucial for developing therapeutic strategies against cancer.

Latest Patents

Véronique Trochon holds a patent for a method of inhibiting angiogenesis or invasion or formation of metastases. This method involves administering a therapeutically effective amount of an active agent, which can include a protein substance or a nucleic acid molecule. The active agents are selected from a group that consists of a disintegrin domain of an adamalysin or its derivatives. This innovative approach has the potential to impact cancer treatment significantly.

Career Highlights

Trochon is affiliated with the National Institute of Health and Medical Research, where she conducts her research. Her work has led to advancements in understanding how to inhibit the processes that allow cancer cells to spread and invade other tissues.

Collaborations

Some of her notable coworkers include He Lu and Claudine Soria. Their collaborative efforts contribute to the ongoing research and development of effective cancer therapies.

Conclusion

Véronique Trochon is a pioneering inventor whose work in angiogenesis inhibition is paving the way for new cancer treatments. Her contributions to medical research are invaluable and highlight the importance of innovation in the fight against cancer.